1. Home
  2. POLA vs CANF Comparison

POLA vs CANF Comparison

Compare POLA & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.78

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.20

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
CANF
Founded
1979
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
6.7M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
POLA
CANF
Price
$1.78
$3.20
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
1.8M
50.3K
Earning Date
04-15-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,801,141.00
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$1.31
$0.17
52 Week High
$5.70
$10.40

Technical Indicators

Market Signals
Indicator
POLA
CANF
Relative Strength Index (RSI) 56.81 49.82
Support Level $1.51 $3.18
Resistance Level $1.81 $3.60
Average True Range (ATR) 0.20 0.14
MACD 0.04 -0.01
Stochastic Oscillator 41.84 37.93

Price Performance

Historical Comparison
POLA
CANF

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: